日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Gut microbiota Lactobacillus johnsonii alleviates hyperuricemia by modulating intestinal urate and gut microbiota-derived butyrate.

肠道菌群约翰逊乳杆菌通过调节肠道尿酸盐和肠道菌群衍生的丁酸盐来缓解高尿酸血症。

Han Rongshuang, Wang Zan, Li Yukun, Ke Leyong, Li Xiang, Li Changgui, Tian Zibin, Liu Xin

Effects of adding urinary alkalizer citrate mixture to febuxostat in gout patients with combined-type hyperuricemia and low urine pH: a prospective cohort study

在伴有混合型高尿酸血症和低尿pH值的痛风患者中,添加尿液碱化剂柠檬酸盐混合物与非布司他联合治疗的效果:一项前瞻性队列研究

Guo, Kai; Li, Changgui; Terkeltaub, Robert; Dalbeth, Nicola; Wang, Xuefeng; Ji, Xiaopeng; Chen, Ying; Cui, Lingling; Liu, Zhen; Li, Xinde; He, Yuwei; Lu, Jie; Sun, Wenyan; Han, Lin; Zhang, Hui; Ji, Aichang; Sun, Mingshu; Wang, Can

An Integrated Risk Prediction Model for Gout Using Clinical Data, Ultrasound Features, and Deep Learning: A Retrospective Multicenter Study

基于临床数据、超声特征和深度学习的痛风综合风险预测模型:一项回顾性多中心研究

Xiao, Lishan; Zhao, Yizhe; Li, Yuchen; Yan, Mengmeng; Liu, Yongming; Li, Changgui; Liu, Manhua; Ning, Chunping

Potency Evaluation and Predictive Quality Control System Construction Strategy for Respiratory Syncytial Virus mRNA Vaccines

呼吸道合胞病毒mRNA疫苗效力评价及预测质量控制体系构建策略

Zhang, Su; Li, Changgui; Quan, Yaru

Perceptions About Asymptomatic Hyperuricemia and Views About Urate-Lowering Therapy in People With Asymptomatic Hyperuricemia

对无症状高尿酸血症的认知以及对无症状高尿酸血症患者降尿酸治疗的看法

Dalbeth, Nicola; Stewart, Sarah; Gamble, Gregory D; Mihov, Borislav; Stamp, Lisa K; Haslett, Janine; Taylor, William J; Merriman, Tony R; Tabi-Amponsah, Adwoa Dansoa; Horne, Anne; Neogi, Tuhina; Pascart, Tristan; Andrés, Mariano; Peral-Garrido, Maria-Luisa; Norkuviene, Eleonora; Vazquez-Mellado, Janitzia; Uhlig, Till; Sun, Mingshu; Li, Changgui; Petrie, Keith J

Efficacy and Safety of Dotinurad Versus Febuxostat for the Treatment of Gout: A Randomized, Multicenter, Double-Blind, Phase 3 Trial in China

多替努拉与非布司他治疗痛风的疗效和安全性比较:一项在中国开展的随机、多中心、双盲3期临床试验

Sun, Jia; Wang, Yu; Cheng, Yongjing; Guo, Dongmei; Hu, Jiankang; Liu, Dongzhou; Gao, Zhengnan; Li, Changgui; Lu, Yibing; Kong, Xiaodan; Liu, Yu; Jiang, Zhenyu; Yi, Bin; Zhang, Hongfeng; Xu, Baijie; Yu, Shihao; Kokan, Rieko; Ishikawa, Kohei; Kawakatsu, Mikiko; Zhang, Zhuoli

Poliovirus shedding after sequential immunization of Sabin-strain inactivated polio vaccines and oral attenuated polio vaccines

先后接种Sabin株灭活脊髓灰质炎疫苗和口服减毒脊髓灰质炎疫苗后脊髓灰质炎病毒的排出情况

Fu, Yuting; Ma, Rufei; Zhao, Zhimei; Mo, Zhaojun; Ying, Zhifang; Li, Jing; Ye, Hui; Li, Guoliang; Liu, Xiaochang; Liang, Jiangli; Ping, Ling; Li, Jingyan; Tao, Junhui; Yang, Qinghai; Wei, Dingkai; Yi, Li; Chen, Hongbo; Wang, Jianfeng; Jiang, Ruiju; Yu, Lei; Cai, Wei; Yang, Wei; Yue, Lei; Xie, Mingxue; Yin, Qiongzhou; Pu, Jing; Hong, Chao; Cai, Lukui; Deng, Yan; Wen, Jiana; Ma, Yan; Gao, Na; Wang, Xiaoyu; Liao, Hongwei; Ji, Qiuyan; Ji, Guang; Hu, Wenzhu; Gu, Qin; He, Xiaoyue; Chu, Han; Fu, Yixian; Zhou, Jian; Wen, Yu; Yang, Xiaolei; Li, Changgui; Shi, Li; Zhao, Ting; Huang, Teng; Yang, Jingsi

Metabolomic profiles underlying gout flares: a prospective study of people with gout

痛风发作的代谢组学特征:一项针对痛风患者的前瞻性研究

Sun, Wenyan; Li, Rui; Dalbeth, Nicola; Cui, Lingling; Liu, Zhen; Wang, Can; Han, Lin; Zhang, Hui; Lu, Jie; Yin, Huiyong; Chen, Haibing; Li, Changgui

Impact of adding urine alkalization therapy to xanthine oxidase inhibitor in gout management: a prospective cohort study

在痛风治疗中,尿液碱化疗法联合黄嘌呤氧化酶抑制剂的效果:一项前瞻性队列研究

Wang, Can; Guo, Kai; Dalbeth, Nicola; Sun, Mingshu; Lu, Jie; Chen, Ying; Zhang, Hui; Wang, Xuefeng; Ji, Xiaopeng; Li, Xinde; Sun, Wenyan; Han, Lin; Cui, Lingling; Liu, Zhen; Ji, Aichang; He, Yuwei; Terkeltaub, Robert; Li, Changgui

Risk of Hepatotoxicity in Patients With Gout Treated With Febuxostat or Benzbromarone: A Propensity Score-Matched Cohort Study

非布司他或苯溴马隆治疗痛风患者发生肝毒性的风险:一项倾向评分匹配队列研究

Sun, Wenyan; Cui, Lingling; Terkeltaub, Robert; Chen, Ying; Li, Xinde; Cheng, Xiaoyu; Liu, Tian; Dalbeth, Nicola; Li, Changgui